Publikationen von M. Wolff
Alle Typen
Zeitschriftenartikel (31)
21.
Zeitschriftenartikel
105 (4), S. 761 - 769 (2010)
Capturing of Cell Culture-Derived Modified Vaccinia Ankara Virus by Ion Exchange and Pseudo-Affinity Membrane Adsorbers. Biotechnology and Bioengineering 22.
Zeitschriftenartikel
161 (2), S. 312 - 316 (2009)
Purification of cell culture-derived influenza virus A/Puerto Rico/8/34 by membrane-based immobilized metal affinity chromatography. Journal of Virological Methods 23.
Zeitschriftenartikel
103 (6), S. 1144 - 1154 (2009)
Sulfated membrane adsorbers for economic pseudo-affinity capture of influenza virus particles. Biotechnology and Bioengineering 24.
Zeitschriftenartikel
154 (1-2), S. 61 - 68 (2008)
Capture of cell culture-derived influenza virus by lectins: strain independent, but host cell dependent. Journal of Virological Methods 25.
Zeitschriftenartikel
31 (6), S. 846 - 857 (2008)
Downstream Processing: From egg to cell culture-derived influenza virus particles. Chemical Engineering and Technology 26.
Zeitschriftenartikel
46 (13), S. 4686 - 4694 (2007)
Hydrodynamic characteristics and expansion behavior of beds containing single and binary-mixtures of particles. Industrial and Engineering Chemistry Research 27.
Zeitschriftenartikel
97 (1), S. 73 - 85 (2007)
Harvesting and concentration of human influenza A virus produced in serum-free mammalian cell culture for the production of vaccines. Biotechnology and Bioengineering 28.
Zeitschriftenartikel
299, S. 251 - 260 (2007)
Direct capture of influenza A virus from cell culture supernatant with Sartobind anion-exchange membrane adsorbers. Journal of Membrane Science 29.
Zeitschriftenartikel
96, S. 932 - 944 (2007)
Purification of cell culture-derived human influenza A virus by size-exclusion and anion-exchange chromatography. Biotechnology and Bioengineering 30.
Zeitschriftenartikel
131 (3), S. 309 - 317 (2007)
Impact of adsorbents selection on affinity purification efficiency of cell culture derived human Influenza viruses. Journal of Biotechnology 31.
Zeitschriftenartikel
25 (5), S. 939 - 947 (2007)
Lectin-affinity chromatography for downstream processing of MDCK cell culture derived human influenza A viruses. Vaccine Buchkapitel (1)
32.
Buchkapitel
Purification of New Biologicals Using Membrane-Based Processes. In: Current Trends and Future Developments on (Bio-) Membranes, S. 123 - 150 (Hg. Basile, A.; Charcosset, C.). Elsevier (2019)
Konferenzbeitrag (1)
33.
Konferenzbeitrag
Accounting for the Entire Influenza Hemagglutinin during a Flu Vaccine Production Process. In: ESACT - Proceedings of the 21st Annual meeting of the European Society for animal cell technology (ESACT), S. 685 - 689. 21st ESACT Meeting , Dublin, Ireland, 07. Juni 2009 - 10. Juni 2009. Berlin (2012)
Meeting Abstract (6)
34.
Meeting Abstract
A single-use chromatographic purification platform for viral gene transfer vectors & viral vaccines. In Proceedings Advancing Manufacture of Cell and Gene Therapies VI, 92. Advancing Manufacture of Cell and Gene Therapies VI, Loews Coronado Bay Hotel Coronado, California, USA, 27. Januar 2019 - 31. Januar 2019. (2019)
35.
Meeting Abstract
Continuous purification of cell culture-derived influenza A virus particles through pseudo- affinity membrane chromatography. In Vaccine Technology VII, 124. Vaccine Technology VII, Mont Tremblant, Canada, 17. Juni 2018 - 22. Juni 2018. (2018)
36.
Meeting Abstract
Purifying viruses with a sheet of paper: Single-use steric exclusion chromatography as a capture platform for vaccine candidates. In Vaccine Technology VII, 128. Vaccine Technology VII, Mont Tremblant, Canada, 17. Juni 2018 - 22. Juni 2018. (2018)
37.
Meeting Abstract
Addressing the challenges of influenza virus-like particles purification. In Vaccine Technology VII, 57. Vaccine Technology VII, Mont Tremblant, Canada, 17. Juni 2018 - 22. Juni 2018. (2018)
38.
Meeting Abstract
Influenza virus capture using membrane chromatography: Improving selectivity by matrix design and pseudo-affinity ligand interactions. In Vaccine Technology VII, 75. Vaccine Technology VII, Mont Tremblant, Canada, 17. Juni 2018 - 22. Juni 2018. (2018)
39.
Meeting Abstract
Pseudo-affinity purification and formulation of a cell-culture derived whole influenza virus vaccine using magnetic sulfated cellulose particles. In Vaccine Technology VI, 57. Vaccine Technology VI, Albufeira, Portugal, 12. Juni 2016 - 17. Juni 2016. (2016)
Vortrag (40)
40.
Vortrag
A single-use purification platform for viral vaccines & gene therapy vectors. International Symposium on the Separation of Proteins, Peptides, and Polynucleotides (ISPPP) 2018, Berlin, Germany (2018)